F.-J. Schmitz - Concepedia

Author

F.-J. Schmitz

Also Known As

C. Schoerner, F J Schmitz, F SCHMITZ, F Schmitz, F. -J. Schmitz, F. J. SCHMITZ, F. J. Schmitz, F. Schmitz, F.-J. SCHMITZ, F.-J. Schmitz

Publications

2.8K

Citations

H-Index

Concepts

All Affiliations

Heinrich Heine University Düsseldorf Utrecht University University Medical Center Utrecht University of Oklahoma

About

F.-J. Schmitz is an author at Heinrich Heine University Düsseldorf specializing in medicine, antimicrobial resistance, and microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	637
2	Health Sciences	7	7	530
3	Engineering	4	4	139
4	Natural Sciences	3	3	116
5	Biochemistry	2	2	33

F.-J. Schmitz

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Epidemiology and Susceptibility of 3,051<i>Staphylococcus aureus</i>Isolates from 25 University Hospitals Participating in the European SENTRY Study Ad C. Fluit, C. L. C. Wielders, J. Verhoef, Journal of Clinical Microbiology	2001	287
Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds Pedro Martinez-Freijo, Ad C. Fluit, F.-J. Schmitz, Journal of Antimicrobial Chemotherapy Integron-negative IsolatesIntegron CarriageAntibiotic ResistanceGram-negative IsolatesDecreased Susceptibility	1998	247
Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals F.-J. Schmitz, R. Sadurski, Angela Kray, Journal of Antimicrobial Chemotherapy	2000	191
The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus F.-J. Schmitz, Ad C. Fluit, Marc Lückefahr, Journal of Antimicrobial Chemotherapy Staphylococcus AureusIn-vitro ActivitiesPharmacotherapyAntimicrobial ChemotherapyAntibiotic Resistance	1998	159
Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates D. Milatović, F.-J. Schmitz, J. Verhoef, Antimicrobial Agents and Chemotherapy	2002	152
Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs) Hélio S. Sader, Susanne Paukner, Zrinka Ivezic‐Schoenfeld, Journal of Antimicrobial Chemotherapy	2012	86
Marine natural products. Xenicin: a diterpenoid possessing a nine-membered ring from the soft coral, Xenia elongata David J. Vanderah, Paul A. Steudler, Leon S. Ciereszko, Journal of the American Chemical Society BiologyXenia ElongataMarine BiotechnologyEngineeringCoral Ecosystems	1977	83
Typing of methicillin-resistant Staphylococcus aureus isolates from Dusseldorf by six genotypic methods F.-J. Schmitz, Matthias Steiert, Hans‐Volker Tichy, Journal of Medical Microbiology Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesPathogen DetectionGenotypic Methods	1998	78
Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997 Ad C. Fluit, Mark E. Jones, F.-J. Schmitz, Antonie van Leeuwenhoek	2000	74
Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR F.-J. Schmitz, Colin R. MacKenzie, B. Hofmann, Journal of Medical Microbiology	1997	70

Page 1